EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Understanding apolipoprotein E as a predominant cause of Alzheimer’s disease

Dylan M Williams, Naaheed Mukadam, Neil M Davies, Emma L Anderson

Brain · 2026-11-11

DOI: 10.1093/brain/awag395 ↗
AbstractBibliografische Angaben

Abstract

Abstract The full contribution of apolipoprotein E (APOE) to Alzheimer’s disease burden in populations may have been overlooked. This is due, in large part, to a lack of recognition that the most common allele of the APOE gene, ε3, increases risk of Alzheimer’s disease relative to the ε2 allele. When the impact of both ε3 and ε4 alleles of APOE are considered, the majority of late-onset Alzheimer’s disease appears to be attributable to differences in APOE function or expression in populations of European ancestry and in other ethnic groups for which we have reliable data. Moreover, most sporadic early-onset Alzheimer’s disease might not occur without the contributions of APOE ε3 and ε4, and the two alleles may be component causes of most forms of Alzheimer’s disease arising from highly penetrant genetic mutations and trisomy 21. Taken together, these lines of epidemiological evidence suggest that APOE is a predominant cause of Alzheimer’s disease, spanning the aetiologies of many forms of the disease. Consequently, almost all prospective cases of Alzheimer’s disease might benefit from the development of therapies to modulate APOE’s role in the disease’s pathophysiology.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →